CeGaT GmbH

General information
CeGaT GmbH
Paul-Ehrlich-Straße 23
72076 Tübingen, Baden-Württemberg
Germany

Contact person: Dirk Biskup, Managing Director
Company main phone: +49 (7071) 5654455
Company main fax:  +49 (7071) 5654456
Website:  https://www.cegat.com
Year founded:2009
Source of foundation:Independent foundation
Name of foundation source:Founded by Dr. Saskia Biskup and Dr. Dirk Biskup
No. of employees: Worldwide:  157
Corporate description / mission:
CeGaT GmbH operates as a specialized diagnostics and sequencing facility that focuses on the application of human genetic analysis within clinical and research environments. The company provides a range of laboratory services centered on Next-Generation Sequencing (NGS) to support the identification of genetic markers related to rare diseases and oncological conditions. Its technical infrastructure supports whole-genome, exome, and transcriptome sequencing, as well as the analysis of somatic mutations and therapeutic indicators for personalized tumor profiling. In addition to diagnostic sequencing, the company provides data generation and genomic assessment services intended for use in medical research, pharmaceutical development, and clinical trials.
State of ownership: Private / independent
Headquarters: HQ: Yes
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Bioinformatics
  • CRO (Contract Research Organization)
  • Diagnostic services
  • Genomics
  • Proteomics
Primary therapeutic areas:
  • Cardiovascular / cardiology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the ear / otology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Genitourinary system / Urology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • R&D
  • Research on contract basis
  • Service company
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Physicians / doctors
Summary Products / Services / Technologies
Description of products:
CancerEssential®
CancerPrecision®
CancerFusionRx®
Harmony® Test
Rhesus-NIPT, etc.
Collaborations & Clients
Partnering strategy / collaborations:
Center for Human Genetics Tübingen
cecava GmbH
Cenata GmbH, etc.
X